Otivio (Norway)
Who can benefit from using FlowOx™?FlowOx™ is recommended for patients of over 18 years who suffer from blood flow deficiencies in the lower limbs such as:a) Peripheral arterial disease (PAD),b) Diabetic and non-diabetic arteriopathic foot and leg ulcers,c) Intermittent claudication and rest pain,d) Foot and lower leg ulcers of mixed aetiology and/or pain/spasticity or discomfort associated with immobility such as paraplegia following spinal cord injury or other neurodegenerative diseases such a
Basic Information
- Category: business
- Website: http://otivio.com/
Documented Facts
- Email: info@otivio.com (No linked source recorded for this statement.)
Evidence and Sources
- Otivio (Norway) — Official Site (official)
- Otivio (Norway) on instagram (social)
- Otivio (Norway) on facebook (social)
- Otivio (Norway) on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Otivio (Norway).
- Canonical profile: https://brandsource.ai/brands/otivio-norway
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/otivio-norway/json-ld
- Citation profile API: https://brandsource.ai/api/brands/otivio-norway/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (85/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Who can benefit from using FlowOx™?FlowOx™ is recommended for patients of over 18 years who suffer from blood flow deficiencies in the lower limbs such as:a) Peripheral arterial disease (PAD),b) Diabetic and non-diabetic arteriopathic foot and leg ulcers,c) Intermittent claudication and rest pain,d) Foot and lower leg ulcers of mixed aetiology and/or pain/spasticity or discomfort associated with immobility such as paraplegia following spinal cord injury or other neurodegenerative diseases such a
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.